UVic Secures $15.2M for Advanced Medical Imaging and Health Research

The University of Victoria (UVic) has secured a significant $15.2 million investment from the Canada Foundation for Innovation (CFI) to modernize its research infrastructure, with a heavy emphasis on health technology and medical imaging. Announced by Karim Bardeesy, Parliamentary Secretary to the Minister of Industry, the funding is delivered through the CFI Innovation Fund. This strategic capital injection is designed to equip Canadian researchers with state-of-the-art instruments, fostering breakthroughs that span from subatomic physics to the molecular foundations of human disease. For the Healthcare and Health IT sectors, this represents a major step forward in the integration of advanced materials science and proteomics into clinical applications.

A primary beneficiary of this funding is the Centre for Advanced Materials and Related Technology (CAMTEC), which will receive $2.95 million. This allocation is specifically earmarked for breakthroughs in medical imaging, microscopy, and additive manufacturing. In the context of modern healthcare, the convergence of quantum computing and medical imaging—both noted as focus areas for CAMTEC—is particularly significant. As diagnostic tools become increasingly reliant on high-resolution data and complex algorithms, the infrastructure at CAMTEC will likely play a pivotal role in developing the next generation of non-invasive diagnostic technologies and precision medical devices. The inclusion of additive manufacturing also suggests a push toward personalized medicine, where 30D-printed biocompatible materials could be tailored to individual patient anatomy.

“

This includes $4.17 million for the Canadian-led portion of the SuperKEKB particle collider project in Japan and $1.5 million for Ocean Networks Canada to upgrade the NEPTUNE observatory.

Simultaneously, the Genome BC Proteomics Centre is set to receive $2.7 million to acquire new tools for studying human, animal, and plant health. Proteomics, the large-scale study of proteins, is a cornerstone of modern drug discovery and disease monitoring. By providing the center with advanced analytical equipment, the funding enables researchers to better understand the mechanisms of disease progression and the specific impacts of environmental stressors. Notably, the research mandate includes investigating the intersection of climate change and health—a growing field of concern for public health officials. This holistic approach to proteomics suggests that UVic is positioning itself to address the complex, multi-factorial health challenges of the 21st century, where environmental factors and biological responses are inextricably linked.